Balyasny Asset Management
PROK icon

Balyasny Asset Management’s ProKidney PROK Stock Holding History

Balyasny Asset Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,683
Closed -$8.69K – 3364
2025
Q2 		$8.69K Buy
+14,683
New +$11.4K ﹤0.01% 2727
2024
Q4 		– Sell
-12,578
Closed -$24.1K – 3163
2024
Q3 		$24.1K Buy
+12,578
New +$28.6K ﹤0.01% 2660
2023
Q4 		– Sell
-56,258
Closed -$258K – 2814
2023
Q3 		$258K Buy
+56,258
New +$538K ﹤0.01% 1964

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Balyasny Asset Management's PROK Position: Q3 2025 in Review

Balyasny Asset Management sold out of ProKidney (PROK) in Q3 2025, closing a stake of 14,683 shares — an estimated $8.69K sold.

Balyasny Asset Management first reported a position in PROK in Q3 2023 and held it in 3 quarters. The position peaked at $258K in Q3 2023. 56 funds tracked by Wall St. Rank hold PROK as of Q3 2025.

  • Balyasny Asset Management reported no remaining ProKidney position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 14,683 ProKidney shares in Q3 2025, an estimated $8.69K.
  • Balyasny Asset Management first reported a position in ProKidney in Q3 2023 and held it in 3 quarters.
  • Balyasny Asset Management's ProKidney position peaked at $258K in Q3 2023.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.